Camptothecin induces DNA strand breaks and is cytotoxic in stimulated normal lymphocytes

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 347-352

  Yamauchi, Takahiro ^a   Yoshida, Akira ^a   Ueda, Takanori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Camptothecin; Comet assay; DNA strand break; Quiescent cells

Indexed keywords

CAMPTOTHECIN; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CELL GROWTH; COMET ASSAY; CYTOTOXICITY; DNA STRAND BREAKAGE; DNA SYNTHESIS; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CELLS, CULTURED; COMET ASSAY; CYTOTOXINS; DNA BREAKS; DNA, SINGLE-STRANDED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; UP-REGULATION;

EID: 78651369200     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1100     Document Type: Article

References (21)

1. Pommier Y: DNA topoisomerase I inhibitors: chemistry, biology and interfacial inhibition. Chem Rev 109: 2894-2902, 2009.
2. Takimoto CH and Arbuck SG: Topoisomearse I targeting agents: the camptothecins. In: Cancer Chemotherapy and Biotherapy. 3rd edition. Chabner BA and Longo DL (eds). Lippincott-Raven Publishers, Philadelphia, pp579-646, 2001.
3. Saltz LB, Cox JV, Blanke C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914, 2000.
4. Venditto VJ and Simanek EE: Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Mol Pharmaceut 7: 307-349, 2010.
5. Pommier Y: Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 6: 789-802, 2006.
6. Pizzolato JF and Saltz LB: The camptothecins. Lancet 361: 2235-2242, 2003.
7. Thomas CJ, Rahier NJ and Hecht SM: Camptothecin: current perspectives. Bioorg Med Chem 12: 1585-1604, 2004.
8. Schneider E, Hsiang YH and Liu LF: DNA topoisomerases as anticancer drug targets. Adv Pharmacol 21: 149-183, 1990.
9. Xu Y and Villalona-Calero MA: Irinotecan: mechanisms of tumour resistance and novel strategies for modulating its activity. Ann Oncol 13: 1841-1851, 2002.
10. Pommier Y, Gupta M, Valenti M and Nieves-Neira W: Cellular resistance to camptothecins. Ann NY Acad Sci 803: 60-73, 1996.
11. Pommier Y, Pourquier P, Fan Y and Strumberg D: Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1400: 83-105, 1998. (Pubitemid 28475097)
12. Pommier Y, Pourquier P, Urasaki Y, Wu J and Laco GS: Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resist Updat 2: 307-318, 1999. (Pubitemid 30070455)
13. Urasaki Y, Takebayashi Y and Pommier Y: Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations. Cancer Res 60: 6577-6580, 2000.
14. Kaufmann S, Charron M, Burke PJ and Karp JE: Changes in topoisomerase I levels and localisation during myeloid maturation in vitro and in vivo. Cancer Res 55: 1255-1260, 1995.
15. Lichtman AH, Segel GB and Lichtman MA: The role of calcium in lymphocyte proliferation. Blood 61: 413-422, 1983.
16. Yamauchi T, Nowak BJ, Keating MJ and Plunkett W: DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Cancer Res 7: 3580-3589, 2001. (Pubitemid 33069998)
17. Yamauchi T, Kawai Y and Ueda T: 1-β-D-arabinofuranosylcytosine is cytotoxic in quiescent normal lymphocytes undergoing DNA excision repair. Cancer Sci 93: 1334-1341, 2002.
18. Yamauchi T, Ogawa M and Ueda T: Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance. Mol Pharmacol 74: 82-91, 2007. (Pubitemid 351872161)
19. Yamauchi T, Nishi R, Kitazumi K, Nakano T and Ueda T: A new high-performance liquid chromatography method determines low production of 9-β-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Oncol Rep 23: 499-504, 2010.
20. Bruno S, Giaretti W and Darzynkiewicz Z: Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication. J Cell Physiol 151: 478-486, 1992.
21. Gallo RC, Whang-Peng J and Adamson RH: Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J Natl Cancer Inst 46: 789-795, 1971.